comparemela.com

Latest Breaking News On - Austell pharmaceuticals - Page 1 : comparemela.com

R101 million rights offer in the works for Ascendis

Ascendis says it will issue 143 million shares at an undiscounted 71 cents per share.

Harry smitScientific groupAustell pharmaceuticalsCalibre investment holdingsAmka productsCalibre investmentSurgical innovations

Ascendis inks R410m agreement to dispose of pharmaceuticals division to Austell

Ascendis entereed into a R590 million loan agreement with Austell Pharmaceuticals in May

Austell pharmaceuticalsAscendis health

Solal owner reconstitutes its board

Since its listing in 2013, Ascendis’ share price has seen a significant drop of more than 93%.

Harry smitBharti harieCarl neethlingLawrence mulaudziGary shayneKarsten wellnerAmaresh chettyAustell pharmaceuticalsAscendis health

Solal owner inks deal with new lender, avoids immediate payment of R550 million loan

Ascendis cut down its whopping debt that stood at R6.7 billion in 2021 by selling some of its assets, bringing it down to R582 million by December.

South africaSouth africanHarry smitBharti harieCarl neethlingAscendis pharmaAmaresh chettyPharmaq holdingsAustell pharmaceuticalsAscendis healthCapex managementAscendis medical

South African Pharmaceutical Market 2022: Pandemic Continues to Cause Business Interruptions and Supply Chain Challenges

/PRNewswire/ The "Pharmaceutical Industry in South Africa 2022" report has been added to ResearchAndMarkets.com s offering. The importance of the.

South africaUnited statesKwazulu natalSouth africanAdcock ingramAlpha pharmAstellas pharmaAfrigen biologicsAurobindo pharmaEli lillyLaura woodWoolworths holdingsVaccines institute of southern africaGoodleaf companyPickn pay storesPharmed pharmaceuticals

vimarsana © 2020. All Rights Reserved.